×

Chemoinformatics Market Size, Share, Trends, Growth Outlook

Chemoinformatics Market Insights, 2023- Forecasts and Opportunities by Type (Chemical Analysis, Drug Discovery, Drug Development, Others), Applications (Pharmaceutical & Chemical Companies, Academic & Research Institutes, Others), Companies and Countries to 2030

  • Home
  • Healthcare
  • Chemoinformatics Market
  • |Published Month : February, 2024
  • |No. of Pages : 180

Technological developments in the field of Chemoinformatics are encouraging its adoption across diverse applications in chemical and medical industries. Both small-scale and large-scale companies are deploying Chemoinformatics for quick and accurate output. The Chemoinformatics report provides insights into the key market dynamics. It also provides forecasts of different types including Chemical Analysis, Drug Discovery, Drug Development, and Others. Further, a wide range of applications including Pharmaceutical & Chemical Companies, Academic & Research Institutes, and Others are analyzed in the report. Profiles of leading companies and country-wise Chemoinformatics market size are also provided in the research work.

Chemoinformatics Market Study Highlights, 2023

  • The global Chemoinformatics Systems Market Size stood at US$ 8.7 billion in 2022 and is poised to register 18.8% growth over the forecast period from 2023 to 2030
  • Chemical Analysis is the largest type of Chemoinformatics systems market with a 42.1% market share. Other key types of Chemoinformatics Systems analyzed in the report include Drug Discovery, Drug Development, and others.  
  • Among different end-user types, pharmaceutical & chemical companies, academic & research institutes, and others are analyzed. Of these, companies stood as the dominant users of Chemoinformatics systems in value terms, with the highest market share in 2022.
  • Driven by rapid adoption across pharmaceutical research companies, North America dominates the global Chemoinformatics Systems market with a dominant market share in value terms.
  • Key market driving forces include increased R&D in pharmaceutical companies, increased demand for personalized medicine, technological advancement in the field, rising prevalence of chronic conditions, increasing geriatric population, and healthcare expenditures, and others are identified among main market dynamics
  • On the other hand, challenges associated with the lack of trained personnel and limited awareness in developing countries, increased R&D expenditure of pharmaceutical companies, lack of awareness in developing countries, and high cost of Chemoinformatics, and the negative impact of COVID-19 restrict the market growth
  • The market is relatively concentrated in nature with intense competitive conditions among leading market players. Intense competitive conditions exist among large conglomerates, resulting in increased mergers and acquisitions activities.

Chemoinformatics Market Outlook to 2030

Chemoinformatics Market Outlook to 2030

Chemoinformatics Market Overview

The Chemoinformatics market is gaining wide popularity across applications, driven by the need for advanced data processes through the use of computational analysis. Chemoinformatics significantly enhances the process of identifying potential compounds and molecules. Accordingly, companies focusing on drug discovery and development are rapidly opting for the modern computational tool that works by bringing together both information technology and chemistry. Avoidance of reductionistic approaches is made possible through Chemoinformatics.

Chemoinformatics Systems are one of the fastest-growing markets in the pharmaceutical and chemical analytical industry, with rapid adoption across developing and developed markets. Technological advancements in the industry are encouraging the wide adoption of different products for applications. Key advantages of Chemoinformatics such as low processing time, reduced manual errors and efforts, automated processes, and others supporting market growth. A wide variety of software types for various applications are witnessing market demand.

A shifting market trend towards Chemoinformatics complete solutions such as consulting, deployment, outcome-based services, and training services are being extended by service and solution providers. Chemoinformatics solutions are widely being procured as companies emphasize achieving high-quality and efficient data on samples. Both large-scale users and small/medium-scale companies are relying on these tools for their drug discovery applications. On the other hand, customized solutions that cater to the exact specifications of the client are also marketed.

The market growth is driven by increased R&D in pharmaceutical companies, increased demand for personalized medicine, ongoing demand for multi-functional systems, advances in technology, flexibility and adaptability of Chemoinformatics systems, availability of a wide range of solutions for diverse applications supports the market growth, Software upgrade offers significant opportunities for companies, rapid adoption of automation in clinical and preclinical studies and others. On the other hand, challenges associated with the negative impact of COVID-19 conditions, higher costs, operational challenges, slower adoption rates in small- and medium-sized Organizations, and lack of trained personnel, and others restrict the market growth.

Chemoinformatics Market Trend - Technological advancements in the field support wide adoption

Chemoinformatics address some of the major bottlenecks encountered in the drug discovery process, predominantly lowering the time and costs of identifying and testing new chemical entities. The technological advancements in Chemoinformatics assist in reducing the time and lowering costs of drug discovery, chemical analysis, and other applications. Further, as hundreds of thousands of individual compounds can be screened per target, a wide number of potential drugs can be researched, providing positive outcomes for research entities.

Driven by the positive impact of Chemoinformatics across drug discovery and validation applications, continuous R&D efforts are being put into the introduction of new mathematical, computer, and biological methods in the Chemoinformatics field. In particular, huge efforts are observed to efficiently handle the massive volume of data produced in the drug discovery process.

Computationally efficient algorithms with accurate predictions for testing the associations between the entire chemical and genomic spaces are widely developed. The technological advances also ensure that the process is also reasonably cheap when compared to the former conventional methodologies.

Chemoinformatics Market Drivers- Rising Prevalence of Chronic Diseases

Chronic diseases and conditions are on the rise worldwide driven by an aging population, growing middle class, rapid urbanization, and sedentary lifestyles. Plasma exchange is mainly used in the treatment of autoimmune diseases, used for removing circulating autoantibodies, immune complexes, complement components, cytokines, and adhesion molecules, along with sensitization of antibody-producing cells to immunosuppressant agents.

According to the World Health Organization, chronic disease prevalence is expected to rise by 57% by the year 2020. Chronic conditions including cardiovascular diseases, kidney disorders, diabetes, neurological conditions, and others are rapidly expanding among the population. For instance, CDC identifies that about 659,000 people in the United States die from heart disease each year.

An estimated 88 million adults have pre-diabetes in the country. The WHO identifies epilepsy (6.27), Alzheimer's and other dementias (4.41), Parkinson’s disease (0.84), Multiple sclerosis (0.4), Migraine (51.3), cerebrovascular disease (9.46), Neuroinfections (2.21), Nutritional and neuropathies (45.29), Neurological injuries (27.82), and others per 1,000 population. About 61,090 new cases of leukemia (all kinds) and 23,660 deaths from leukemia (all kinds) and about 20,240 deaths in the US according to the American Cancer Society.

Chemoinformatics Market Share Analysis- Chemical Analysis dominates the global markets

The primary application of Chemoinformatics is in the storage, indexing, and searching of data related to compounds. Mining, information retrieval, information extraction, and machine learning techniques are used for chemical analysis.

Chemoinformatics Market Share- Chemical Analysis, Drug Discovery, Development

Different applications of informatics in the chemical field include the storage and retrieval of chemical structures for analysis. New techniques such as combinatorial chemistry and high-throughput screening generate huge amounts of data.

Cross-linking the obtained data with existing information and uploading the data to the internet is performed. In addition, prediction of the physical, chemical, or biological properties of compounds, analytical chemistry analysis of data, analysis of organic reactions and organic synthesis, and others are widely observed applications of Chemoinformatics.

Chemoinformatics Market Segmentation

Types

  • Chemical Analysis
  • Drug Discovery
  • Drug Development
  • Others

Applications

  • Pharmaceutical & Chemical Companies
  • Academic & Research Institutes
  • Others

Companies Profiled in the Research Study-

  • Dassault Systems SE
  • ChemAxon
  • BioSolveIT GmbH
  • Scilligence Corporation
  • Agilent Technologies, Inc.
  • Bio-Rad Laboratories, Inc
  • BIOVIA
  • Cambridgesoft Corp
  • ChemAxon Inc
  • Molecular Discovery Ltd

Regions

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa

1. Executive Summary

1.1 Introduction to Chemoinformatics Markets

1.2 Chemoinformatics Market Size Outlook, 2021- 2030

1.3 Growth Opportunities in Chemoinformatics Industry

1.4 Winning Strategies for the post-pandemic future

 

2. Report Guide

2.1 Market Definition and Scope

2.2 Market Segmentation

2.3 Research Methodology

2.4 Forecast Methodology

2.5 List of Abbreviations

 

3. Growth Opportunity Analysis

3.1 Key Chemoinformatics Market Trends

3.1.1 Increased R&D in Pharmaceutical Companies

3.1.2 Increased demand for personalized medicine

3.1.3 Technological advancements in the field support wide adoption     

 

3.2 Key Chemoinformatics Market Growth Drivers

3.2.1 Rising Prevalence of Chronic Diseases

3.2.2 Increasing Geriatric population

3.2.3 Growing healthcare expenditures

 

3.3 Key Chemoinformatics Market Growth Restraints

3.3.1 Limited awareness in developing countries

3.3.2 High cost of Chemoinformatics

 

4 Chemoinformatics Market Outlook – Scenario Analysis

4.1 Low Growth Case Scenario Forecasts: Chemoinformatics Market Size Outlook to 2030

4.2 Reference Growth Case Scenario Forecasts: Chemoinformatics Market Size Outlook to 2030

4.3 High Growth Case Scenario Forecasts: Chemoinformatics Market Size Outlook to 2030

 

5. Chemoinformatics Market Segmentation- Outlook by Type

5.1 Chemoinformatics Market Share Analysis by Type, 2023

5.2 Chemical Analysis Market Outlook to 2030

5.3 Drug Discovery Market Outlook to 2030

5.4 Drug Development Market Outlook to 2030

5.5 Other Chemoinformatics Market Outlook to 2030

 

6. Chemoinformatics Market Segmentation- Outlook by Application

6.1 Chemoinformatics Market Share Analysis by Application, 2023

6.2: Pharmaceutical & Chemical Companies Market Outlook to 2030

6.3: Academic & Research Institutes Market Outlook to 2030

6.4 Others Market Outlook to 2030

 

7. North America Chemoinformatics Market Outlook and Opportunities to 2030

7.1 Market Snapshot, 2023

7.2 North America Chemoinformatics Market Growth Opportunities

7.2.1 North America Chemoinformatics Market Outlook by Type, 2021 to 2030

7.2.2 North America Chemoinformatics Market Outlook by Application, 2021 to 2030

7.2.3 North America Chemoinformatics Market Outlook by Country, 2021 to 2030

7.3 United States Chemoinformatics Market Outlook, 2021 to 2030

7.4 Canada Chemoinformatics Market Outlook, 2021 to 2030

7.5 Mexico Chemoinformatics Market Outlook, 2021 to 2030

 

8. Europe Chemoinformatics Market Outlook and Opportunities to 2030

8.1 Market Snapshot, 2023

8.2 Europe Chemoinformatics Market Growth Opportunities

8.2.1 Europe Chemoinformatics Market Outlook by Type, 2021 to 2030

8.2.2 Europe Chemoinformatics Market Outlook by Application, 2021 to 2030

8.2.3 Europe Chemoinformatics Market Outlook by Country, 2021 to 2030

8.3 Germany Chemoinformatics Market Outlook, 2021 to 2030

8.4 France Chemoinformatics Market Outlook, 2021 to 2030

8.5 United Kingdom Chemoinformatics Market Outlook, 2021 to 2030

8.6 Spain Chemoinformatics Market Outlook, 2021 to 2030

8.7 Italy Chemoinformatics Market Outlook, 2021 to 2030

8.8 Other Europe Chemoinformatics Market Outlook, 2021 to 2030

 

9. Asia Pacific Chemoinformatics Market Outlook and Opportunities to 2030

9.1 Market Snapshot, 2023

9.2 Asia Pacific Chemoinformatics Market Growth Opportunities

9.2.1 Asia Pacific Chemoinformatics Market Outlook by Type, 2021 to 2030

9.2.2 Asia Pacific Chemoinformatics Market Outlook by Application, 2021 to 2030

9.2.3 Asia Pacific Chemoinformatics Market Outlook by Country, 2021 to 2030

9.3 China Chemoinformatics Market Outlook, 2021 to 2030

9.4 Japan Chemoinformatics Market Outlook, 2021 to 2030

9.5 India Chemoinformatics Market Outlook, 2021 to 2030

9.6 South Korea Chemoinformatics Market Outlook, 2021 to 2030

9.7 Indonesia Chemoinformatics Market Outlook, 2021 to 2030

9.8 Other Asia Pacific Chemoinformatics Market Outlook, 2021 to 2030

 

10. South and Central America Chemoinformatics Market Outlook and Opportunities to 2030

10.1 Market Snapshot, 2023

10.2 South and Central America Chemoinformatics Market Growth Opportunities

10.2.1 South and Central America Chemoinformatics Market Outlook by Type, 2021 to 2030

10.2.2 South and Central America Chemoinformatics Market Outlook by Application, 2021 to 2030

10.2.3 South and Central America Chemoinformatics Market Outlook by Country, 2021 to 2030

10.3 Brazil Chemoinformatics Market Outlook, 2021 to 2030

10.4 Argentina Chemoinformatics Market Outlook, 2021 to 2030

10.5 Other Latin America Chemoinformatics Market Outlook, 2021 to 2030

 

11. Middle East and Africa Chemoinformatics Market Outlook and Opportunities to 2030

11.1 Market Snapshot, 2023

11.2 Middle East and Africa Chemoinformatics Market Growth Opportunities

11.2.1 Middle East and Africa Chemoinformatics Market Outlook by Type, 2021 to 2030

11.2.2 Middle East and Africa Chemoinformatics Market Outlook by Application, 2021 to 2030

11.2.3 Middle East and Africa Chemoinformatics Market Outlook by Country, 2021 to 2030

11.3 Saudi Arabia Chemoinformatics Market Outlook, 2021 to 2030

11.4 United Arab Emirates (the UAE) Chemoinformatics Market Outlook, 2021 to 2030

11.5 Other Middle East Chemoinformatics Market Outlook, 2021 to 2030

11.6 Egypt Chemoinformatics Market Outlook, 2021 to 2030

11.7 South Africa Chemoinformatics Market Outlook, 2021 to 2030

11.8 Other Africa Chemoinformatics Market Outlook, 2021 to 2030

 

12. Profiles of major world Chemoinformatics Companies

12.1 Dassault Systems SE

- Key Statistics

- Business Operations

- Products and Services Offered

- SWOT Analysis

- Financial Profile

12.2 ChemAxon

- Key Statistics

- Business Operations

- Products and Services Offered

- SWOT Analysis

- Financial Profile

12.3 BioSolveIT GmbH

- Key Statistics

- Business Operations

- Products and Services Offered

- SWOT Analysis

- Financial Profile

12.4 Scilligence Corporation

- Key Statistics

- Business Operations

- Products and Services Offered

- SWOT Analysis

- Financial Profile

12.5 Agilent Technologies, Inc.

- Key Statistics

- Business Operations

- Products and Services Offered

- SWOT Analysis

- Financial Profile

12.6 Bio-Rad Laboratories, Inc

- Key Statistics

- Business Operations

- Products and Services Offered

- SWOT Analysis

- Financial Profile

12.7 BIOVIA

- Key Statistics

- Business Operations

- Products and Services Offered

- SWOT Analysis

- Financial Profile

12.8 Cambridgesoft Corp

- Key Statistics

- Business Operations

- Products and Services Offered

- SWOT Analysis

- Financial Profile

- Financial Profile

12.9 ChemAxon Inc

- Key Statistics

- Business Operations

- Products and Services Offered

- SWOT Analysis

- Financial Profile

- Financial Profile

12.10 Molecular Discovery Ltd

- Key Statistics

- Business Operations

- Products and Services Offered

- SWOT Analysis

- Financial Profile

- Financial Profile

 

13. Appendix

13.1 Publisher’s Expertise

13.2 List of Tables and Charts

13.3 List of Exhibits

13.4 Legal Disclaimer                     

Types

  • Chemical Analysis
  • Drug Discovery
  • Drug Development
  • Others

Applications

  • Pharmaceutical & Chemical Companies
  • Academic & Research Institutes
  • Others

Frequently Asked Questions

Related Reports